Kaushlya Medical And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.90 M
as on 27-06-2024
- Revenue 11.30%
(FY 2022)
- Profit -5.72%
(FY 2022)
- Ebitda 0.46%
(FY 2022)
- Net Worth 16.85%
(FY 2022)
- Total Assets 5.01%
(FY 2022)
About Kaushlya Medical And Research Centre
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Anisha Garg, Kiran Garg, and Rahul Garg serve as directors at the Company.
- CIN/LLPIN
U85110DL1998PTC091950
- Company No.
091950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kaushlya Medical And Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anisha Garg  | Director | 27-Aug-2020 | Current |
| Kiran Garg | Director | 28-Jan-1998 | Current |
| Rahul Garg | Director | 28-Jan-1998 | Current |
Financial Performance of Kaushlya Medical And Research Centre.
Kaushlya Medical And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.3% increase. The company also saw a slight decrease in profitability, with a 5.72% decrease in profit. The company's net worth Soared by an impressive increase of 16.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaushlya Medical And Research Centre?
In 2020, Kaushlya Medical And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shashiprabha Medical And Research Centre Private LimitedActive 11 years 3 monthsKiran Garg and Rahul Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 01 Dec 2014 | ₹0.90 M | Open |
How Many Employees Work at Kaushlya Medical And Research Centre?
Unlock and access historical data on people associated with Kaushlya Medical And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaushlya Medical And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaushlya Medical And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
